ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Ankylosing spondylitis (AS)"

  • Abstract Number: L21 • 2014 ACR/ARHP Annual Meeting

    Striking Discrepancy in the Development of Anti-Drug Antibodies (ADA) in Patients with Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) in Response to Infliximab (INF) and Its Biosimilar CT-P13

    Jürgen Braun1, Xenofon Baraliakos1, Alex Kudrin2, H. Kim3 and Sang Joon Lee2, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2CELLTRION, Inc., Incheon, South Korea, 3CELLTRION, Inc, Incheon, Republic of Korea, Incheon, South Korea

    Background/Purpose: The differences between RA and AS have been recently highlighted (1). There is evidence that there are major clinical, pathophysiological and genetic differences. In…
  • Abstract Number: 2610 • 2014 ACR/ARHP Annual Meeting

    The Role of IL-20 in the Pathogenesis of Ankylosing Spondylitis with Peripheral Joint Involvement

    Göksal Keskin1, Baris Mavi2, Lale Ozisik3, Rahsan Ilikci4 and Mehmet Yildiz2, 1Immunology, Medical School of Ankara, Ankara, Turkey, 2Internal Medicine, Diskapi Training and Research Hospital, Ankara, Turkey, 3Internal Medicine, MD, Ankara, Turkey, 4Basic Immunology, BC, Ankara, Turkey

    Background/Purpose The interleukin-20 (IL-20) is a pro-inflammatory cytokine of the IL-10 family and sequence amino acid is very similar. It has been reported to be…
  • Abstract Number: 2149 • 2014 ACR/ARHP Annual Meeting

    Relationship Between the Magnitude of Bone Formation in the Anterior Vertebral Corners, As Assessed through 18F-Fluoride Uptake, and Lumbar Spine Bone Mineral Density in Patients with Ankylosing Spondylitis

    Seung-Geun Lee1, Eun-Kyoung Park1, Geun-Tae Kim2, Sang-Yeob Lee3 and Joung-Wokk Lee4, 1Divsion of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea, 4Divsion of Rheumatology, Department of Internal Medicine, Busan St. Marys center, Busan, South Korea

    Background/Purpose: 18F-fluoride uptake represents active osteoblastic bone synthesis. We investigated the relationship between the magnitude of bone formation in anterior vertebral corners, as assessed through…
  • Abstract Number: 612 • 2014 ACR/ARHP Annual Meeting

    Association of Platelet Endothelial Cell Adhesion Molecule-1 and beta1 Integrin Gene Polymorphisms with Uveitis Development in Ankylosing Spondylitis

    Seong-Wook Kang1, Seung-Taek Song1, Su-Jin Yoo2, Mi-Kyoung Lim3, Dong-Hyuk Sheen4, In-Seol Yoo2, Jinhyun Kim1 and Seung-Cheol Shim1, 1Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, South Korea, 2Departmen of Internal medicine, Chungnam National University School of Medicine, Daejeon, South Korea, 3Rheumatology, Eulji University Hospital, Daejeon, South Korea, 4Department of Internal Medicine, Eulji University Hospital, Daejeon, South Korea

    Background/Purpose Genetic factors provide over 90% of the overall susceptibility to ankylosing spondylitis (AS) and recent studies have focused on non-major histocompatibility complex genes. The…
  • Abstract Number: 578 • 2014 ACR/ARHP Annual Meeting

    Female Patients but Not Male Patients with Ankylosing Spondylitis Are at Increased Risk of Developing Ischemic Heart Disease: A Population-Based Cohort Study

    Ivette Essers1,2, Carmen Stolwijk1,2, Annelies Boonen3,4, Marie L. De Bruin5, Marloes Bazelier5, Frank de Vries5,6,7,8 and Astrid Van Tubergen1,2, 1School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, 2Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Care and Public Health Research Institute, Maastricht University Medical Center, Maastricht, Netherlands, 5Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands, 6Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, Netherlands, 7MRC Lifecourse Epidemiology Unit, Southampton General Hospital, Southampton, United Kingdom, 8Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands

    Background/Purpose: It is well recognized that rheumatoid arthritis is an independent risk factor for cardiovascular disease. For ankylosing spondylitis (AS), the literature on this risk…
  • Abstract Number: 2607 • 2014 ACR/ARHP Annual Meeting

    Fatigue in Ankylosing Spondylitis: A Multivariable Analysis Implicates Inflammation As the Key Determinant of Disability

    Mohamed Bedaiwi1, Arane Thavaneswaran2, Nigil Haroon3, Ammepa Anton4 and Robert D. Inman5, 1Division of Rheumatology, Toronto Western Hospital, clinical and research fellow, Toronto, ON, Canada, 2University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Toronto Western Research Institute, Toronto, ON, Canada, 4Rheumatology, University Health Network, Toronto, ON, Canada, 5Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Fatigue is one of the cardinal features of ankylosing spondylitis (AS). The clinical and laboratory correlates of fatigue in AS however are not well…
  • Abstract Number: 1919 • 2014 ACR/ARHP Annual Meeting

    HLA-B27 Expression Shapes the Intestinal Microbiota

    Mark Asquith1, Phoebe Lin2, Tejpal Gill3, Justine Debelius4, Patrick Stauffer5, Sean Davin5, Gail Ackermann4, Robert A. Colbert3, Rob Knight4 and James Rosenbaum1,6, 1Division of Rheumatology, Oregon Health and Science University, Portland, OR, 2Casey Eye Institute, Oregon Health and Science University, Portland, OR, 3NIAMS/NIH, Bethesda, MD, 4University of Colorado Boulder, Boulder, CO, 5Oregon Health and Science University, Portland, OR, 6Dever's Eye Institute, Legacy Hospital, Portland, OR

    Background/Purpose The intestinal microbiota plays a central role in both health and disease. Beyond shaping local immune responses in the gut, it is increasingly clear…
  • Abstract Number: 608 • 2014 ACR/ARHP Annual Meeting

    Identification of Novel Autoantibodies in Patients with Ankylosing Spondylitis Using Human Protein Microarray

    Matthew Presby1, Mark J. Soloski1, John A. Flynn2, Clifton O. Bingham III1, Michael M. Ward3 and Grant H. Louie4, 1Johns Hopkins University, Baltimore, MD, 2Dept of Medicine, Johns Hopkins University, Baltimore, MD, 3Bldg 10 CRC Rm 4-1339, NIAMS/NIH, Bethesda, MD, 4Rheumatology, Johns Hopkins University, Baltimore, MD

    Background/Purpose:   Ankylosing spondylitis (AS) is an immune-mediated disease for which the search for autoantibodies has been elusive. Conventional immunoserological approaches are slow and limited…
  • Abstract Number: 574 • 2014 ACR/ARHP Annual Meeting

    Do Extra-Articular Manifestations Influence Outcome in Ankylosing Spondylitis? a 12 Year Follow-up Study

    Ivette Essers1,2, Sofia Ramiro3,4, Carmen Stolwijk1,2, Marc Blaauw5, Robert Landewé6,7, Désirée M. van der Heijde8, Filip van Den Bosch9, Maxime Dougados10 and Astrid van Tubergen2,11, 1School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, 2Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center/University of Amsterdam, Amsterdam, Netherlands, 4Rheumatology, Hospital Garcia de Orta, Almada, Portugal, 5Department of Internal Medicine, Catharina Hospital, Eindhoven, Netherlands, 6Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 7Rheumatology, Atrium Medical Center, Heerlen, Netherlands, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium, 10Rheumatology, Hopital Cochin, Descartes University, Paris, France, 11Maastricht University Medical Center, Maastricht, Netherlands

    Background/Purpose: Extra-articular manifestations (EAMs), such as acute anterior uveitis (AAU), inflammatory bowel disease (IBD), and psoriasis contribute to diagnosis, classification criteria, and choice of treatment…
  • Abstract Number: 2985 • 2014 ACR/ARHP Annual Meeting

    Autoantibodies to 14-3-3η Are Novel Biomarkers Associated with Inflammation and  Radiographic Progression in Ankylosing Spondylitis

    Walter P. Maksymowych1, Stephanie Wichuk1, RG Lambert2, Mairead Murphy3 and Anthony Marotta4, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Radiology, University of Alberta, Edmonton, AB, Canada, 3Augurex Life Sciences Corp., North Vancouver, BC, Canada, 41423 Dempsey Road, Augurex Life Sciences Corp., North Vancouver, BC, Canada

    Background/Purpose 14-3-3η is a ubiquitous intracellular chaperone protein that is expressed extracellularly in rheumatoid arthritis and mediates inflammatory cascades that result in expression of inflammatory…
  • Abstract Number: 2582 • 2014 ACR/ARHP Annual Meeting

    Serum Levels of Bone Morphogenetic Protein-7 and Sclerostin Are Elevated in Ankylosing Spondylitis, but Not Linked with Structural Damage

    Weiping Kong1, Xiaotong WANG1, Tongliang Zhou2, Yue Jin3, Qingwen TAO1, Yuan Xu1, Yingze Zhang1, Jianming WANG1 and Xiaoping Yan1, 1Department of TCM Rheumatology, China-Japan Friendship Hospital, BEIJING, China, 2CLINICAL RESEARCH INSTITUTE OF IMMUNOLOGY, China-Japan Friendship Hospital, BEIJING, China, 3COMBINATION OF WESTERN AND CHINESE MEDICINE, Beijing University of Chinese Medicine, BEIJING, China

    Background/Purpose Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by new bone formation that progressively leads to ankylosis and functional disability. The mechanisms of…
  • Abstract Number: 1913 • 2014 ACR/ARHP Annual Meeting

    Rosuvastatin Induced Carotid Plaque Regression in Patients with Inflammatory Joint Diseases

    Silvia Rollefstad1, Eirik Ikdahl1, Jonny Hisdal2, Inge C. Olsen3, Ingar Holme4, Hilde Berner Hammer5, Knut T. Smerud6, G Kitas7, Terje R. Pedersen8, Tore K. Kvien9 and Anne Grete Semb1, 1Preventive Cardio-Rheuma clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Section of Vascular Investigations, Uslo University Hospital-Aker, Oslo, Norway, 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Department of biostatistics, epidemiology and health economics, Oslo University Hospital, Oslo, Norway, 5Postboks 23 Vinderen, Diakonhjemmet Hospital, Oslo, Norway, 6Smerud Medical Research International AS, Oslo, Norway, 7The Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, 8Faculty of Medicine, University of Oslo, Oslo, Norway, 9PsAID taskforce, EULAR, Zurich, Switzerland

    Background/Purpose Patients with rheumatoid arthritis (RA) and carotid artery plaques (CP) have increased risk of acute coronary syndromes. Statin treatment with low density lipoprotein cholesterol…
  • Abstract Number: 619 • 2014 ACR/ARHP Annual Meeting

    Effect of ERAP1 Knockdown on Conformation of HLA-B27 and Other HLA Class I Molecules in Human Monocytic Cells

    Tri M. Tran1, Sohee Hong1, Jehad H. Edwan2 and Robert A. Colbert1, 1NIAMS/NIH, Bethesda, MD, 2NIAMS NIH, Bethesda, MD

    Background/Purpose Polymorphisms in endoplasmic reticulum (ER) aminopeptidase 1 (ERAP1) are associated with ankylosing spondylitis, Behcet’s disease, and psoriasis/psoriatic arthritis, where HLA class I alleles are…
  • Abstract Number: 573 • 2014 ACR/ARHP Annual Meeting

    Three-Year Course and Prediction of Physical Functioning in Ankylosing Spondylitis Patients Treated with TNF-Inhibitors

    Salima F.E. van Weely1, Eva L. Kneepkens1, Mike T. Nurmohamed1, Joost Dekker1,2 and Irene E. van der Horst-Bruinsma3, 1Reade, centre for Rehabilitation and Rheumatology, Amsterdam, Netherlands, 2Rehabilitation Medicine, Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, 3Rheumatology, VU University Medical Centre, Amsterdam, Netherlands

    Background/Purpose: Currently, only limited information is available on the long-term course of limitations in physical functioning and spinal mobility in Ankylosing Spondylitis (AS) patients receiving…
  • Abstract Number: 2986 • 2014 ACR/ARHP Annual Meeting

    Fat Metaplasia on MRI of the Sacroiliac Joints Is a Lead Indicator of Radiographic Progression in the Spine of Patients with Ankylosing Spondylitis

    Walter P. Maksymowych1, S Wichuk2, P Chiowchanwisawakit3, RG Lambert4 and Sj Pedersen5, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3Mahidol University, Bangkok, Thailand, 4Radiology, University of Alberta, Edmonton, AB, Canada, 5Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark

    Fat Metaplasia on MRI of the Sacroiliac joints is a Lead Indicator of Radiographic Progression in the Spine of Patients with Ankylosing SpondylitisMaksymowych WP, Wichuk…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 67
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology